
PBM REFORM & REIMBUSEMENT EQUITY
Pharmacy Middlemen Shouldn’t Decide Who Gets Treatment
PBMs and insurers are blocking coverage of compounded medications — not because they’re unproven, but because they don’t fit the profit model.
Pharmacy Benefit Managers (PBMs) routinely deny reimbursement for compounded medications. They reject claims, set arbitrary exclusions, and lock out compounders from provider networks. That forces patients to pay out of pocket—or go without treatment entirely.
This is profit-driven gatekeeping, not healthcare.
Who’s Paying the Price
Families managing chronic conditions with compounded solutions
Patients priced out of commercial options
Providers forced to change care plans to fit insurance rules
Independent pharmacies competing with vertically integrated giants
WHAT NEEDS TO CHANGE
PBMs must be held accountable for denying legitimate care. That means enforcing transparency, ending discriminatory coverage policies, and giving patients and prescribers the freedom to choose what works.
Copyright 2025